Home » Topics » Conferences

Conferences
RSS

Serum complement activation is implicated in the pathogenesis of CHF

Nov. 13, 1998

Vasopressin V2 receptor antagonist beneficial in mouse model of PKD

Nov. 13, 1998

VPA-985 characterized as potent, selective, orally active V2 antagonist

Nov. 13, 1998

BG-9719 has potent natriuretic effects in patients with CHF

Nov. 13, 1998

McMaster University researchers target potential gene therapies for arthritis

Nov. 13, 1998

Bristol-Myers Squibb initiates phase III HBV clinical trials; phase II data reported

Nov. 13, 1998

SB-205553 used to investigate role of 5-HT2C receptor antagonists in PD therapy

Nov. 13, 1998

Leflunomide reduces symptoms of rheumatoid arthritis, slows disease progression in new studies

Nov. 13, 1998

First clinical results reported for novel gene therapy in coronary artery disease

Nov. 12, 1998

SPBN: a free radical scavenger with potential in pediatric head trauma

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...